References
- Arslan M, Gencer N, Arslan O, Ozensoy Guler O. 2012. In vitro efficacy of some cattle drugs on bovine serum paraoxonase1 (PON1) activity. J Enzyme Inhib Med Chem. 27:722–729.
- Aviram M, Rosenblat M, Bisgaier C, Newton RS, Primo-Parmo SL, La Du BN. 1998. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest. 101:1581–1590.
- Bozzetta E, Pezzolato M, Maurella C, Varello K, Richelmi GB, Draisci R, Ferranti C, D’Angelo A, Caramelli M. 2011. Development of an enhanced histopathological approach to detect low-dose dexamethasone illicit treatment in veal calves. Food Addit Contam Part A. 28:1187–1192.
- Cacciatore G, Eisenberg SWF, Situ C, Mooney MH, Delahaut P, Klarenbeek S, Huet AC, Bergwerff AA, Elliott CT. 2009. Effect of growth-promoting 17β-estradiol, 19-nortestosterone and dexamethasone on circulating levels of nine potential biomarker candidates in veal calves. Anal Chim Acta. 637:351–359.
- Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B, Orecchia P, Zardi L, Righetti PG. 2004. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis. 25:1327–1333.
- Commission Regulation (EU) No. 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. OJ EC L 15:1–72, 20.1.2010.
- Courant F, Pinel G, Bichon E, Monteau F, Antignac JP, Le Bizec B. 2009. Development of a metabolomic approach based on liquid chromatography-high resolution mass spectrometry to screen for clenbuterol abuse in calves. Analyst. 134:1637–1646.
- Courtheyn D, Le Bizec B, Brambilla G, De Brabander HF, Cobbaert E, Van De Wiele M, Vercammen J, De Wasch K. 2002. Recent developments in the use and abuse of growth promoters. Anal Chim Acta. 473:71–82.
- D’Alessandro A, Zolla L. 2012. We are what we eat: food safety and proteomics. J Proteome Res. 11:26–36.
- Draisci R, Montesissa C, Santamaria B, D’Ambrosio C, Ferretti G, Merlanti R, Ferranti C, De Liguoro M, Cartoni C, Pistarino E, et al. 2007. Integrated analytical approach in veal calves administered the anabolic androgenic steroids boldenone and boldione: urine and plasma kinetic profile and changes in plasma protein expression. Proteomics. 7:3184–3193.
- Gardini G, Del Boccio P, Colombatto S, Testore G, Corpillo D, Di Ilio C, Urbani A, Nebbia C. 2006. Proteomic investigation in the detection of the illicit treatment of calves with growth-promoting agents. Proteomics. 6:2813–2822.
- Giantin M, Lopparelli RM, Zancanella V, Martin PG, Polizzi A, Gallina G, Gottardo F, Montesissa C, Ravarotto L, Pineau T, Dacasto M. 2010. Effects of illicit dexamethasone upon hepatic drug metabolizing enzymes and related transcription factors mRNAs and their potential use as biomarkers in cattle. J Agric Food Chem. 58:1342–1349.
- Gottardo F, Brscic M, Pozza G, Ossensi C, Contiero B, Marin A, Cozzi G. 2008. Administration of dexamethasone per os in finishing bulls. I. Effects on productive traits, meat quality and cattle behaviour as indicator of welfare. Animal. 2:1073–1079.
- Ludwig SK, Smits NG, Cannizzo FT, Nielen MW. 2013. Potential of treatment-specific protein biomarker profiles for detection of hormone abuse in cattle. J Agric Food Chem. 61:4514–4519.
- McGrath TF, van Meeuwen JA, Massart AC, de Pauw E, Delahaut P, Buijs J, Bergwerff AA, Elliott CT, Mooney MH. 2013. Effect-based proteomic detection of growth promoter abuse. Anal Bioanal Chem. 405:1171–1179.
- Meyer HH. 2001. Biochemistry and physiology of anabolic hormones used for improvement of meat production. Acta Pathol Microbiol Immunol Scandinavia. 109:1–8.
- Mooney MH, Bergwerff AA, van Meeuwen JA, Luppa PB, Elliott CT. 2009. Biosensor-based detection of reduced sex hormone-binding globulin binding capacities in response to growth-promoter administrations. Anal Chim Acta. 637:235–240.
- Mooney MH, Le Bizec B, Elliott CT. 2009. Combining biomarker screening and mass-spectrometric analysis to detect hormone abuse in cattle. Trends Anal Chem. 28:665–675.
- Mooney MH, Situ C, Cacciatore G, Hutchinson T, Elliott C, Bergwerff A. 2008. Plasma biomarker profiling in the detection of growth promoter use in calves. Biomarkers. 13:246–256.
- Pinel G, Weigel S, Antignac JP, Mooney MH, Elliott C, Nielen MWF, Le Bizec B. 2010. Targeted and untargeted profiling of biological fluids to screen for anabolic practices in cattle. Trends Anal Chem. 29:1269–1280.
- Serratosa J, Blass A, Rigau B, Mongrell B, Rigau T, Tortadès M, Tolosa E, Aguilar C, Ribó O, Balagué J. 2006. Residues from veterinary medicinal products, growth promoters and performance enhancers in food-producing animals: a European Union perspective. Rev Sci Tech. 25:637–653.
- Smits NGE, Bremer MGEG, Ludwig SKJ, Nielen MWF. 2012. Development of a flow cytometric immunoassay for recombinant bovine somatotropin-induced antibodies in serum of dairy cows. Drug Test Anal. 4:362–367.
- Stella R, Biancotto G, Krogh M, Angeletti R, Pozza G, Sorgato MC, James P, Andrighetto I. 2011. Protein expression changes in skeletal muscle in response to growth promoter abuse in beef cattle. J Proteome Res. 10:2744–2757.
- Zhao M, Célérier I, Bousquet E, Jeanny JC, Jonet L, Savoldelli M, Offret O, Curan A, Farman N, Jaisser F, Behar-Cohen F. 2012. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest. 122:2672–2679.